Vol. 5 No. 4S (2011)

Vol. 5 No. 4S (2011)

Published: 2011-09-30

Imatinib dose optimisation following the disease progression in a patient with metastatic GIST

Mariangela Parodi, Monica Boitano, Luciano Canobbio

3-6
- PDF
Imatinib as adjuvant therapy for high risk GIST: a case report

Patrizia Lista, Agostino Ponzetti

7-12
- PDF
Appropriate durations of adjuvant imatinib in patients with high-risk gastrointestinal stromal tumor (GIST) the better choice, for the year 2010

Lucia Tozzi

13-16
- PDF